3-129483544-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_052989.3(IFT122):​c.1713G>T​(p.Ser571Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0111 in 1,614,034 control chromosomes in the GnomAD database, including 164 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S571S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.011 ( 12 hom., cov: 32)
Exomes 𝑓: 0.011 ( 152 hom. )

Consequence

IFT122
NM_052989.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.41

Publications

3 publications found
Variant links:
Genes affected
IFT122 (HGNC:13556): (intraflagellar transport 122) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This cytoplasmic protein contains seven WD repeats and an AF-2 domain which function by recruiting coregulatory molecules and in transcriptional activation. Mutations in this gene cause cranioectodermal dysplasia-1. A related pseudogene is located on chromosome 3. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2013]
IFT122 Gene-Disease associations (from GenCC):
  • cranioectodermal dysplasia 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • cranioectodermal dysplasia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 3-129483544-G-T is Benign according to our data. Variant chr3-129483544-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 343243.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.41 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.011 (1673/152174) while in subpopulation SAS AF = 0.0294 (141/4800). AF 95% confidence interval is 0.0254. There are 12 homozygotes in GnomAd4. There are 838 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IFT122NM_052989.3 linkc.1713G>T p.Ser571Ser synonymous_variant Exon 15 of 30 ENST00000348417.7 NP_443715.1 Q9HBG6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IFT122ENST00000348417.7 linkc.1713G>T p.Ser571Ser synonymous_variant Exon 15 of 30 1 NM_052989.3 ENSP00000324005.4 Q9HBG6-1

Frequencies

GnomAD3 genomes
AF:
0.0110
AC:
1669
AN:
152056
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0146
Gnomad AMI
AF:
0.0746
Gnomad AMR
AF:
0.0138
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0291
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00868
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.0110
AC:
2757
AN:
251444
AF XY:
0.0122
show subpopulations
Gnomad AFR exome
AF:
0.0148
Gnomad AMR exome
AF:
0.00726
Gnomad ASJ exome
AF:
0.00407
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00217
Gnomad NFE exome
AF:
0.00982
Gnomad OTH exome
AF:
0.0109
GnomAD4 exome
AF:
0.0111
AC:
16179
AN:
1461860
Hom.:
152
Cov.:
32
AF XY:
0.0117
AC XY:
8481
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.0160
AC:
534
AN:
33476
American (AMR)
AF:
0.00704
AC:
315
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00444
AC:
116
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39698
South Asian (SAS)
AF:
0.0304
AC:
2624
AN:
86254
European-Finnish (FIN)
AF:
0.00241
AC:
129
AN:
53420
Middle Eastern (MID)
AF:
0.0208
AC:
120
AN:
5766
European-Non Finnish (NFE)
AF:
0.0105
AC:
11686
AN:
1112000
Other (OTH)
AF:
0.0108
AC:
653
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1019
2039
3058
4078
5097
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
484
968
1452
1936
2420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0110
AC:
1673
AN:
152174
Hom.:
12
Cov.:
32
AF XY:
0.0113
AC XY:
838
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0145
AC:
604
AN:
41528
American (AMR)
AF:
0.0138
AC:
211
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.0294
AC:
141
AN:
4800
European-Finnish (FIN)
AF:
0.00122
AC:
13
AN:
10614
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00869
AC:
591
AN:
67992
Other (OTH)
AF:
0.0104
AC:
22
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
87
173
260
346
433
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00430
Hom.:
2
Bravo
AF:
0.0119
EpiCase
AF:
0.00949
EpiControl
AF:
0.0113

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 13, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cranioectodermal dysplasia 1 Benign:1
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cranioectodermal dysplasia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Connective tissue disorder Benign:1
Apr 22, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
0.012
DANN
Benign
0.66
PhyloP100
-2.4
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150174636; hg19: chr3-129202387; COSMIC: COSV105893782; COSMIC: COSV105893782; API